1

Chr. Hansen

Chr. Hansen
Leadership team

Mr. Mauricio Graber (CEO, Pres & Member of Exec. Board)

Ms. Lise Skaarup Mortensen (Exec. VP, CFO & Member of Exec. Board)

Dr. Thomas Schafer Ph.D. (Chief Science Advisor)

Products/ Services
Biopharma, Biotechnology, Food Processing, Health Care, Nutrition
Number of Employees
1,000 - 20,000
Headquarters
Hørsholm, Hovedstaden, Denmark
Established
1874
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
51C.F
Social Media
Overview
Location
Summary
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.
History

The company is named for its founder, Christian D. A. Hansen, a pioneering Danish chemist whose work focused on enzymes. Hansen began the company in 1874 as a joint venture with pharmacist H.P. Madsen.

Initial products included animal rennet for cheese-making as well as annatto-based coloring agents for butter and cheese. Operations in the United States were begun in 1878. Their lines soon expanded to include starter cultures for cheese, yogurt and sour cream. In 1890 Hansen purchased an island for a manufacturing facility on the Mohawk River of New York and named it Hansen Island. Hansen's son Johannes took over the company in 1916 upon his father's death. That same year, the company began production in England to bypass the German World War I blockade of exports to Great Britain and beyond. Facilities in Italy and Germany followed in 1936 during the inter-war period. By 1951, Hansen began production in Australia. Further international expansion in places such as South America followed, and from the 1970s to the 1990s saw a period of acquisition of other firms. The company released its first probiotic in 1987. In 1991, the Lundbeck Foundation obtained majority control of the company and initiated a major restructuring into a holding company format. Additional growth and consolidation followed, and Chr. Hansen Group was spun off into a separate, independent company in May 2005 which allowed the company to focus on long-term growth strategies rather than quarterly goals.

Mission
Chr. Hansen’s mission is to create value in the foodchain by providing natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
Vision
Chr. Hansen’s vision is to be the global leader in natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
Key Team

Mr. Torsten Steenholt (Exec. VP of Global Operations)

Sanne Seyer-Hansen (Head of Media Relations)

Mr. Henrik Joerck Nielsen (Exec. VP & Chief Scientific Officer)

Ms. Alice Larsen (Corp. VP of HR)

Mr. Laurent Hubert (VP & Head of Food, Beverage and Diagnostics)

Anders Mohr Christensen (VP Group Strategy & Investor Relations)

Ms. Winnie Hoejvang Bugel (Corp. VP of Compliance & Corp. Affairs)

Recognition and Awards
Chr. Hansen has been recognized with numerous awards, including the Danish National Export Award, the Global Forum Corporate Social Responsibility Award and the European Food Ingredient Innovation Award.
References
Chr. Hansen
Leadership team

Mr. Mauricio Graber (CEO, Pres & Member of Exec. Board)

Ms. Lise Skaarup Mortensen (Exec. VP, CFO & Member of Exec. Board)

Dr. Thomas Schafer Ph.D. (Chief Science Advisor)

Products/ Services
Biopharma, Biotechnology, Food Processing, Health Care, Nutrition
Number of Employees
1,000 - 20,000
Headquarters
Hørsholm, Hovedstaden, Denmark
Established
1874
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
51C.F
Social Media